• PDF: Delivered by email usually within 48 UK business hours.

Global Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

  • Publication Date:March 2009
  • Publisher:GlobalData
  • Product Type: Report
  • Pages:237

Global Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

This Medical Device report is an essential source for key information and data relating to the global Drug Delivery Devices market. The report provides overview of key trends, regulatory information in key countries, pricing & reimbursement, drivers and restraints, future outlook, pipeline products, news, financial deals and competitive landscape and key developments in the global Drug Delivery Devices market. It also offers global and country level, detailed and comprehensive coverage of market revenue, volume, distribution and company share information.

Scope

This report provides detailed global, regional key countries (United States (US), Germany, United Kingdom (UK), France, Italy, Spain, Japan, Canada, China, India, Australia, Brazil) data on market size by volume and value for categories in the Drug Delivery devices market.

Medical Equipment Sectors in this Report:

Drug delivery devices, Needle-free Injections, Inhalation Systems, Metered Dose Inhaler, Dry powder inhaler, Infusion Systems, Infusion pumps, Syringe pumps, and Disposable Infusion sets.

  • Key Companies AstraZeneca, GlaxoSmithKline, Cardinal Health, Baxter International, and Boehringer Ingelheim.
  • It gives key company share information for leading competitors, revenues by distribution channel and forecasts of market values at global, regional and country level.
  • It also provides overview of the market structure, key trends, drivers and restraints, future outlook, competitive landscape and key developments.
  • All figures are based on rigorous research methodologies including in-depth primary and secondary research.

Reasons to Buy

  • A single source to fulfill all of your business and competitor intelligence needs
  • Gain a strong understanding of the drug delivery devices at a global level, with break downs for 12 countries
  • Evaluate and compare the attractiveness of the market in different geographies.
  • Identify growth segments and opportunities in the industry.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched.
  • Analyze the competitiveness of the market in different countries and regions and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news.
  • Do deals with an understanding of how competitors are financed, and the mergers and acquisitions, Partnerships that have shaped the market.
  • Identify and analyze the strengths and weaknesses of the medical Technology/biomedical/medical Equipment Industry incumbents.
  • Plan your market entry strategy by comparing the sales pace in different countries
  • 1 Table of Contents
    • 1.1 List of Tables
  • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of Markets Covered in This Report
    • 3.1 Drug delivery devices
    • 3.2 Needle-free Injections
    • 3.3 Inhalation Systems
      • 3.3.1 Metered Dose Inhaler
      • 3.3.2 Dry powder inhaler
    • 3.4 Infusion Systems
      • 3.4.1 Infusion pumps
      • 3.4.2 Syringe pumps
      • 3.4.3 Disposable Infusion sets
  • 4 Drug Delivery Devices Cross Country Comparison
  • 5 Drug Delivery Devices in Global
    • 5.1 Drug Delivery Devices, Global, Overall Revenue ($ mn), 2000-2015
    • 5.2 Drug Delivery Devices, Global, Category Volume (Units), 2000-2015
    • 5.3 Drug Delivery Devices, Global, Company share (2006-2007)
  • 6 Drug Delivery Devices In United States
    • 6.1 Drug Delivery Devices, United States, Overall Revenue ($ mn), 2000-2015
    • 6.2 Drug Delivery Devices, United States, Category Volume (Units), 2000-2015
    • 6.3 Drug Delivery Devices, United States, Distribution Share (2006-2007)
      • 6.3.1 Infusion Systems Distribution Share (2006-2007)
      • 6.3.2 Inhalation Systems Distribution Share (2006-2007)
      • 6.3.3 Needle Free Injections Distribution Share (2006-2007)
    • 6.4 Drug Delivery Devices, United States, Company Share (2006-2007)
      • 6.4.1 Drug Delivery Devices, United States, Company Share (2006-2007)
      • 6.4.2 Infusion Systems, United States, Company Share (2006-2007)
      • 6.4.3 Inhalation Systems, United States, Company Share (2006-2007)
      • 6.4.4 Needle Free Injections, United States, Company Share (2006-2007)
  • 7 Drug Delivery Devices In Japan
    • 7.1 Drug Delivery Devices, Japan, Overall Revenue ($ mn), 2000-2015
    • 7.2 Drug Delivery Devices, Japan, Category Volume (Units), 2000-2015
    • 7.3 Drug Delivery Devices, Japan, Distribution Share (2006-2007)
      • 7.3.1 Infusion Systems Distribution Share (2006-2007)
      • 7.3.2 Inhalation Systems Distribution Share (2007-2008)
      • 7.3.3 Needle Free Injections Distribution Share (2007-2008)
    • 7.4 Drug Delivery Devices, Japan, Company Share (2006-2007)
      • 7.4.1 Drug Delivery Devices, Japan, Company Share (2006-2007)
      • 7.4.2 Infusion Systems, Japan, Company Share (2006-2007)
      • 7.4.3 Inhalation Systems, Japan, Company Share (2006-2007)
      • 7.4.4 Needle Free Injections, Japan, Company Share (2006-2007)
  • 8 Drug Delivery Devices In Germany
    • 8.1 Drug Delivery Devices, Germany, Overall Revenue ($ mn), 2000-2015
    • 8.2 Drug Delivery Devices, Germany, Category Volume (Units), 2000-2015
    • 8.3 Drug Delivery Devices, Germany, Distribution Share (2006-2007)
      • 8.3.1 Infusion Systems Distribution Share (2006-2007)
      • 8.3.2 Inhalation Systems Distribution Share (2007-2008)
      • 8.3.3 Needle Free Injections Distribution Share (2007-2008)
    • 8.4 Drug Delivery Devices, Germany, Company Share (2006-2007)
      • 8.4.1 Drug Delivery Devices, Germany, Company Share (2006-2007)
      • 8.4.2 Infusion Systems, Germany, Company Share (2006-2007)
      • 8.4.3 Inhalation Systems, Germany, Company Share (2006-2007)
      • 8.4.4 Needle Free Injections, Germany, Company Share (2006-2007)
  • 9 Drug Delivery Devices In France
    • 9.1 Drug Delivery Devices, France, Overall Revenue ($ mn), 2000-2015
    • 9.2 Drug Delivery Devices, France, Category Volume (Units), 2000-2015
    • 9.3 Drug Delivery Devices, France, Distribution Share (2006-2007)
      • 9.3.1 Infusion Systems Distribution Share (2006-2007)
      • 9.3.2 Inhalation Systems Distribution Share (2007-2008)
      • 9.3.3 Needle Free Injections Distribution Share (2007-2008)
    • 9.4 Drug Delivery Devices, France Company Share (2006-2007)
      • 9.4.1 Drug Delivery Devices, France Company Share (2006-2007)
      • 9.4.2 Infusion Systems, France, Company Share (2006-2007)
      • 9.4.3 Inhalation Systems, France, Company Share (2006-2007)
      • 9.4.4 Needle Free Injections, France, Company Share (2006-2007)
  • 10 Drug Delivery Devices In China
    • 10.1 Drug Delivery Devices, China, Overall Revenue ($ mn), 2000-2015
    • 10.2 Drug Delivery Devices, China, Category Volume (Units), 2000-2015
    • 10.3 Drug Delivery Devices, China, Distribution Share (2006-2007)
      • 10.3.1 Infusion Systems Distribution Share (2006-2007)
      • 10.3.2 Inhalation Systems Distribution Share (2007-2008)
    • 10.4 Drug Delivery Devices, China, Company Share (2006-2007)
      • 10.4.1 Drug Delivery Devices, China, Company Share (2006-2007)
      • 10.4.2 Infusion Systems, China, Company Share (2006-2007)
      • 10.4.3 Inhalation Systems, China, Company Share (2006-2007)
  • 11 Drug Delivery Devices In United Kingdom
    • 11.1 Drug Delivery Devices, United Kingdom, Overall Revenue ($ mn), 2000-2015
    • 11.2 Drug Delivery Devices, United Kingdom, Category Volume (Units), 2000-2015
    • 11.3 Drug Delivery Devices, United Kingdom, Distribution Share (2006-2007)
      • 11.3.1 Infusion Systems Distribution Share (2006-2007)
      • 11.3.2 Inhalation Systems Distribution Share (2007-2008)
      • 11.3.3 Needle Free Injections Distribution Share (2007-2008)
    • 11.4 Drug Delivery Devices, United Kingdom, Company Share (2006-2007)
      • 11.4.1 Drug Delivery Devices, United Kingdom, Company Share (2006-2007)
      • 11.4.2 Infusion Systems, United Kingdom, Company Share (2006-2007)
      • 11.4.3 Inhalation Systems, United Kingdom, Company Share (2006-2007)
      • 11.4.4 Needle Free Injections, United Kingdom, Company Share (2006-2007)
  • 12 Drug Delivery Devices In Italy
    • 12.1 Drug Delivery Devices, Italy, Overall Revenue ($ mn), 2000-2015
    • 12.2 Drug Delivery Devices, Italy, Category Volume (Units), 2000-2015
    • 12.3 Drug Delivery Devices, Italy, Distribution Share (2006-2007)
      • 12.3.1 Infusion Systems Distribution Share (2006-2007)
      • 12.3.2 Inhalation Systems Distribution Share (2006-2007)
      • 12.3.3 Needle Free Injections Distribution Share (2007-2008)
    • 12.4 Drug Delivery Devices, Italy, Company Share (2006-2007)
      • 12.4.1 Drug Delivery Devices, Italy, Company Share (2006-2007)
      • 12.4.2 Infusion Systems, Italy, Company Share (2006-2007)
      • 12.4.3 Inhalation Systems, Italy, Company Share (2006-2007)
      • 12.4.4 Needle Free Injections, Italy, Company Share (2006-2007)
  • 13 Drug Delivery Devices In Spain
    • 13.1 Drug Delivery Devices, Spain, Overall Revenue ($ mn), 2000-2015
    • 13.2 Drug Delivery Devices, Spain, Category Volume (Units), 2000-2015
    • 13.3 Drug Delivery Devices, Spain, Distribution Share (2006-2007)
      • 13.3.1 Infusion Systems Distribution Share (2006-2007)
      • 13.3.2 Inhalation Systems Distribution Share (2007-2008)
      • 13.3.3 Needle Free Injections Distribution Share (2007-2008)
    • 13.4 Drug Delivery Devices, Spain Company Share (2006-2007)
      • 13.4.1 Drug Delivery Devices, Spain Company Share (2006-2007)
      • 13.4.2 Infusion Systems, Spain, Company Share (2006-2007)
      • 13.4.3 Inhalation Systems, Spain, Company Share (2006-2007)
      • 13.4.4 Needle Free Injections, Spain, Company Share (2006-2007)
  • 14 Drug Delivery Devices In Canada
    • 14.1 Drug Delivery Devices, Canada, Overall Revenue ($ mn), 2000-2015
    • 14.2 Drug Delivery Devices, Canada, Category Volume (Units), 2000-2015
    • 14.3 Drug Delivery Devices, Canada, Distribution Share (2006-2007)
      • 14.3.1 Infusion Systems Distribution Share (2006-2007)
      • 14.3.2 Inhalation Systems Distribution Share (2007-2008)
      • 14.3.3 Needle Free Injections Distribution Share (2007-2008)
    • 14.4 Drug Delivery Devices, Canada, Company Share (2006-2007)
      • 14.4.1 Drug Delivery Devices, Canada, Company Share (2006-2007)
      • 14.4.2 Infusion Systems, Canada, Company Share (2006-2007)
      • 14.4.3 Inhalation Systems, Canada, Company Share (2006-2007)
      • 14.4.4 Needle Free Injections, Canada, Company Share (2006-2007)
  • 15 Drug Delivery Devices In Brazil
    • 15.1 Drug Delivery Devices, Brazil, Overall Revenue ($ mn), 2000-2015
    • 15.2 Drug Delivery Devices, Brazil, Category Volume (Units), 2000-2015
    • 15.3 Drug Delivery Devices, Brazil, Distribution Share (2006-2007)
      • 15.3.1 Infusion Systems Distribution Share (2006-2007)
      • 15.3.2 Inhalation Systems Distribution Share (2007-2008)
    • 15.4 Drug Delivery Devices, Brazil, Company Share (2006-2007)
      • 15.4.1 Drug Delivery Devices, Brazil, Company Share (2006-2007)
      • 15.4.2 Infusion Systems, Brazil, Company Share (2006-2007)
      • 15.4.3 Inhalation Systems, Brazil, Company Share (2006-2007)
  • 16 Drug Delivery Devices In Australia
    • 16.1 Drug Delivery Devices, Australia, Overall Revenue ($ mn), 2000-2015
    • 16.2 Drug Delivery Devices, Australia, Category Volume (Units), 2000-2015
    • 16.3 Drug Delivery Devices, Australia, Distribution Share (2006-2007)
      • 16.3.1 Infusion Systems Distribution Share (2006-2007)
      • 16.3.2 Inhalation Systems Distribution Share (2007-2008)
    • 16.4 Drug Delivery Devices, Australia Company Share (2006-2007)
      • 16.4.1 Drug Delivery Devices, Australia Company Share (2006-2007)
      • 16.4.2 Infusion Systems, Australia, Company Share (2006-2007)
      • 16.4.3 Inhalation Systems, Australia, Company Share (2006-2007)
  • 17 Drug Delivery Devices In India
    • 17.1 Drug Delivery Devices, India, Overall Revenue ($ mn), 2000-2015
    • 17.2 Drug Delivery Devices, India, Category Volume (Units), 2000-2015
    • 17.3 Drug Delivery Devices, India, Distribution Share (2006-2007)
      • 17.3.1 Infusion Systems Distribution Share (2006-2007)
      • 17.3.2 Inhalation Systems Distribution Share (2007-2008)
    • 17.4 Drug Delivery Devices, India, Company Share (2006-2007)
      • 17.4.1 Drug Delivery Devices, India, Company Share (2006-2007)
      • 17.4.2 Infusion Systems, India, Company Share (2006-2007)
      • 17.4.3 Inhalation Systems, India, Company Share (2006-2007)
  • 18 Overview of Key Companies in Global Drug Delivery Devices Market
    • 18.1 AstraZeneca PLC Company Profile
      • 18.1.1 Company Overview
    • 18.2 GlaxoSmithKline plc Company Profile
      • 18.2.1 Company Overview
    • 18.3 Cardinal Health, Inc. Company Profile
      • 18.3.1 Company Overview
      • 18.3.2 Value Chain Analysis
    • 18.4 Baxter International Inc. Company Profile
      • 18.4.1 Company Overview
      • 18.4.2 Value Chain Analysis
    • 18.5 Boehringer Ingelheim GmbH Company Profile
      • 18.5.1 Company Overview
      • 18.5.2 Value Chain Analysis
    • 18.6 Hospira, Inc. Company Profile
      • 18.6.1 Company Overview
      • 18.6.2 Value Chain Analysis
      • 18.6.3 Hospira, Inc. Pipeline Products
    • 18.7 Smiths Medical Company Profile
      • 18.7.1 Company Overview
      • 18.7.2 Value Chain Analysis
    • 18.8 Novartis AG
      • 18.8.1 Company Overview
    • 18.9 Fresenius SE
      • 18.9.1 Company Overview
    • 18.10 B. Braun Melsungen AG Company Profile
      • 18.10.1 Company Overview
      • 18.10.2 Value Chain Analysis
    • 18.11 Consort Medical plc Company Profile
      • 18.11.1 Company Overview
      • 18.11.2 Value Chain Analysis
      • 18.11.3 Consort Medical plc Pipeline Products
    • 18.12 Bioject Medical Technologies Inc
      • 18.12.1 Company Overview
      • 18.12.2 Value Chain Analysis
      • 18.12.3 Bioject Medical Technologies Inc. Pipeline Products
    • 18.13 Corium International, Inc. Company Profile
      • 18.13.1 Company Overview
      • 18.13.2 Corium International, Inc. Pipeline Products
    • 18.14 SkyePharma PLC Company Profile
      • 18.14.1 Company Overview
      • 18.14.2 SkyePharma PLC Pipeline Products
    • 18.15 TheraJect, Inc. Company Profile
      • 18.15.1 Company Overview
      • 18.15.2 TheraJect, Inc. Pipeline Products
    • 18.16 AKAS Medical Company Profile
      • 18.16.1 Company Overview
    • 18.17 Aveva Drug Delivery Systems Company Profile
      • 18.17.1 Company Overview
    • 18.18 B. Braun Medical Inc. Company Profile
      • 18.18.1 Company Overview
    • 18.19 Daiken Medical Co., Ltd. Company Profile
      • 18.19.1 Company Overview
    • 18.20 Eksigent Technologies, LLC Company Profile
      • 18.20.1 Company Overview
    • 18.21 Inyx, Inc. Company Profile
      • 18.21.1 Company Overview
    • 18.22 IOMED, Inc. Company Profile
      • 18.22.1 Company Overview
    • 18.23 MicroDose Technologies, Inc. Company Profile
      • 18.23.1 Company Overview
    • 18.24 Nanotherapeutics, Inc. Company Profile
      • 18.24.1 Company Overview
    • 18.25 Novagali Pharma SA Company Profile
      • 18.25.1 Company Overview
    • 18.26 Plenum Technologies Private Limited Company Profile
      • 18.26.1 Company Overview
    • 18.27 pSivida Limited Company Profile
      • 18.27.1 Company Overview
    • 18.28 SEDAT Company Profile
      • 18.28.1 Company Overview
    • 18.29 Trudell Medical International Company Profile
      • 18.29.1 Company Overview
      • 18.29.2 Trudell Medical International Pipeline Products
  • 19 Financial Deals Landscape
    • 19.1 Acquisition
      • 19.1.1 Nicholas Piramal India Acquires MINRAD INTERNATIONAL
      • 19.1.2 Access Pharmaceuticals Acquires MacroChem
      • 19.1.3 Arkema Acquires Oxford Performance Materials
      • 19.1.4 Endo Pharmaceuticals to Acquire Indevus Pharmaceuticals
    • 19.2 Partnerships
      • 19.2.1 DSM Biomedical Enters Into An Agreement With MediVas
      • 19.2.2 Covidien Enters Into an Agreement with Depomed
      • 19.2.3 MonoSol Rx Enters Into An Agreement With Midatech
      • 19.2.4 Acusphere Signs An Agreement With Cephalon
      • 19.2.5 Stallergenes Enters Into an Agreement with Catalent Pharma Solutions and the Medical House
      • 19.2.6 Merck & Co Terminates License Agreement with SurModics
  • 20 Recent Developments
    • 20.1 Strategy and Business Planning
      • 20.1.1 Mar 03, 2009: Acusphere Reveals Cost Reduction Plans
      • 20.1.2 Nov 25, 2008: Anika Therapeutics Terminates US Distribution Agreements with Artes Medical for ELEVESS
      • 20.1.3 Nov 21, 2008: Vical Plans to Close Research Facility
    • 20.2 Legal and Regulatory
      • 20.2.1 Jan 12, 2009: Kalur Law Files Lawsuits against Pain Pump and Local Anesthetic Makers
      • 20.2.2 Jan 07, 2009: BD Settles Lawsuit with Ultimed
      • 20.2.3 Oct 17, 2008: Brualdi Files Class Action Lawsuit Against Elan
    • 20.3 Government and Public Interest
      • 20.3.1 Mar 10, 2009: Risk of Burns during MRI Scans from Transdermal Drug Patches with Metallic Backings
      • 20.3.2 Mar 05, 2009: FDA Warns About Risk Of Wearing Medicated Patches During MRIs
      • 20.3.3 Oct 07, 2008: RNA Molecules, Delivery System Improve Vaccine Responses, Effectiveness
      • 20.3.4 Oct 02, 2008: Nanodiamond Drug Device Could Transform Cancer Treatment
    • 20.4 Product News
      • 20.4.1 Mar 10, 2009: Vyteris Announces Phase II Clinical Trial Commencement of Smart Patch Technology for Infertility Treatment
      • 20.4.2 Feb 13, 2009: VGX Pharmaceuticals Files Device Master File Amendment with the FDA for CELLECTRA Device
      • 20.4.3 Jan 19, 2009: AeonClad Biomedical Utilizes AeonCoat Technology to the Drug Delivery and Medical Devices Markets
      • 20.4.4 Jan 15, 2009: Teva Specialty Pharmaceuticals Donates ProAir HFA to Direct Relief International Help Economically Disadvantaged Asthma Sufferers Breathe Easier
      • 20.4.5 Dec 31, 2008: Embozene Color-Advanced Microspheres Embolization Platform's First US Implants
      • 20.4.6 Dec 16, 2008: CeloNova Announces FDA Clearance for Embozene Color-Advanced Microspheres Embolization Platform
      • 20.4.7 Nov 23, 2008: Thirty-Seven Patients Treated With Ultrasound Accelerated Catheter Direct Pharmacological Thrombolysis
      • 20.4.8 Nov 20, 2008: Trellis Peripheral Infusion System Removes Blood Clots In Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
      • 20.4.9 Nov 13, 2008: Delsite Presents Nasal Powder And Synthetic Typhoid Vaccine Technologies At The 2nd Vaccines Asia Conference
      • 20.4.10 Nov 11, 2008: Philips' Intelligent Pill Targets Drug Development And Treatment For Digestive Tract Diseases
      • 20.4.11 Nov 03, 2008: Medgenics Announces Encouraging Preliminary Data For Phase I/II Clinical Trial Of Epodure In Renal Anemia
      • 20.4.12 Oct 17, 2008: Preliminary Phase I Safety Data For Preventive HIV Vaccine Delivered By Ichor's TriGrid To Be Presented At AIDS Conference
      • 20.4.13 Oct 15, 2008: Lilly Launches New FORTEO Delivery Device
      • 20.4.14 Sep 29, 2008: Baxter's Antimicrobial IV Technology Shown To Kill Six Common Pathogens, Including MRSA and VRE
      • 20.4.15 Sep 19, 2008: Delcath Systems Targeted Drug Delivery Technology to Be Presented At Western Angiographic And Interventional Society Annual Meeting
      • 20.4.16 Sep 09, 2008: Navilyst Medical Introduces New EZ Huber Safety Infusion Set
    • 20.5 Product Approvals
      • 20.5.1 Jan 08, 2009: Medegen Announces 510(k) Clearance for MaxGuard Advanced Luer-Activated Device With Antimicrobial Technology
      • 20.5.2 Dec 04, 2008: FlowMedica Receives FDA Clearance For New Indication For The Benephit Infusion Systems
  • 21 Appendix
    • 21.1 Global Markets Direct Research Methodology
    • 21.2 Coverage
    • 21.3 Secondary Research
    • 21.4 Primary Research
    • 21.5 Models
    • 21.6 Forecasts
    • 21.7 Expert Panel Validation
    • 21.8 Currency Conversion
    • 21.9 Contact Us
    • 21.10 Disclaimer
  • 1.1 List of Tables
    • Table 1: Drug Delivery Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Table 2: Drug Delivery Devices, Global, Overall Revenue ($ mn), 2000-2015
    • Table 3: Drug Delivery Devices, Global, Cross-Category Analysis, 2000-2015
    • Table 4: Drug Delivery Devices, Global, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 5: Drug Delivery Devices, Global, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 6: Drug Delivery Devices, Global, Category Volume (Units), 2000-2015
    • Table 7: Drug Delivery Devices, Global, Category Volume (Units), Historic, 2000-2008
    • Table 8: Drug Delivery Devices, Global, Category Volume (Units), Forecast, 2008-2015
    • Table 9: Drug Delivery Devices, Global, Company share by Revenue ($ mn), 2006-2007
    • Table 10: Drug Delivery Devices, United States, Overall Revenue ($ mn), 2000-2015
    • Table 11: Drug Delivery Devices, United States, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 12: Drug Delivery Devices, United States, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 13: Drug Delivery Devices, United States, Category Volume (Units), 2000-2015
    • Table 14: Drug Delivery Devices, United States, Category Volume (Units), Historic, 2000-2008
    • Table 15: Drug Delivery Devices, United States, Category Volume (Units), Forecast, 2008-2015
    • Table 16: Infusion Systems, United States, Distribution Share by Revenue ($mn), 2007-2008
    • Table 17: Inhalation Systems, United States, Distribution Share by Revenue ($mn), 2007-2008
    • Table 18: Needle Free Injections, United States, Distribution Share by Revenue ($mn), 2007-2008
    • Table 19: Drug Delivery Devices, United States, Company Share by Revenue ($ mn), 2006-2007
    • Table 20: Infusion Systems, United States, Company Share by Revenue ($ mn), 2006-2007
    • Table 21: Inhalation Systems, United States, Company Share by Revenue ($ mn), 2006-2007
    • Table 22: Needle Free Injections, United States, Company Share by Revenue ($ mn), 2006-2007
    • Table 23: Drug Delivery Devices, Japan, Overall Revenue ($ mn), 2000-2015
    • Table 24: Drug Delivery Devices, Japan, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 25: Drug Delivery Devices, Japan, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 26: Drug Delivery Devices, Japan, Category Volume (Units), 2000-2015
    • Table 27: Drug Delivery Devices, Japan, Category Volume (Units), Historic, 2000-2008
    • Table 28: Drug Delivery Devices, Japan, Category Volume (Units), Forecast, 2008-2015
    • Table 29: Infusion Systems, Japan, Distribution Share by Revenue ($mn), 2007-2008
    • Table 30: Inhalation Systems, Japan, Distribution Share by Revenue ($mn), 2007-2008
    • Table 31: Needle Free Injections, Japan, Distribution Share by Revenue ($mn), 2007-2008
    • Table 32: Drug Delivery Devices, Japan, Company Share by Revenue ($ mn), 2006-2007
    • Table 33: Infusion Systems, Japan, Company Share by Revenue ($ mn), 2006-2007
    • Table 34: Inhalation Systems, Japan, Company Share by Revenue ($ mn), 2006-2007
    • Table 35: Needle Free Injections, Japan, Company Share by Revenue ($ mn), 2006-2007
    • Table 36: Drug Delivery Devices, Germany, Overall Revenue ($ mn), 2000-2015
    • Table 37: Drug Delivery Devices, Germany, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 38: Drug Delivery Devices, Germany, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 39: Drug Delivery Devices, Germany, Category Volume (Units), 2000-2015
    • Table 40: Drug Delivery Devices, Germany, Category Volume (Units), Historic, 2000-2008
    • Table 41: Drug Delivery Devices, Germany, Category Volume (Units), Forecast, 2008-2015
    • Table 42: Infusion Systems, Germany, Distribution Share by Revenue ($mn), 2007-2008
    • Table 43: Inhalation Systems, Germany, Distribution Share by Revenue ($mn), 2007-2008
    • Table 44: Needle Free Injections, Germany, Distribution Share by Revenue ($mn), 2007-2008
    • Table 45: Drug Delivery Devices, Germany, Company Share by Revenue ($ mn), 2006-2007
    • Table 46: Infusion Systems, Germany, Company Share by Revenue ($ mn), 2006-2007
    • Table 47: Inhalation Systems, Germany, Company Share by Revenue ($ mn), 2006-2007
    • Table 48: Needle Free Injections, Germany, Company Share by Revenue ($ mn), 2006-2007
    • Table 49: Drug Delivery Devices, France, Overall Revenue ($ mn), 2000-2015
    • Table 50: Drug Delivery Devices, France, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 51: Drug Delivery Devices, France, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 52: Drug Delivery Devices, France, Category Volume (Units), 2000-2015
    • Table 53: Drug Delivery Devices, France, Category Volume (Units), Historic, 2000-2008
    • Table 54: Drug Delivery Devices, France, Category Volume (Units), Forecast, 2008-2015
    • Table 55: Infusion Systems, France, Distribution Share by Revenue ($mn), 2007-2008
    • Table 56: Inhalation Systems, France, Distribution Share by Revenue ($mn), 2007-2008
    • Table 57: Needle Free Injections, France, Distribution Share by Revenue ($mn), 2007-2008
    • Table 58: Drug Delivery Devices, France Company Share by Revenue ($ mn), 2006-2007
    • Table 59: Infusion Systems, France, Company Share by Revenue ($ mn), 2006-2007
    • Table 60: Inhalation Systems, France, Company Share by Revenue ($ mn), 2006-2007
    • Table 61: Needle Free Injections, France, Company Share by Revenue ($ mn), 2006-2007
    • Table 62: Drug Delivery Devices, China, Overall Revenue ($ mn), 2000-2015
    • Table 63: Drug Delivery Devices, China, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 64: Drug Delivery Devices, China, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 65: Drug Delivery Devices, China, Category Volume (Units), 2000-2015
    • Table 66: Drug Delivery Devices, China, Category Volume (Units), Historic, 2000-2008
    • Table 67: Drug Delivery Devices, China, Category Volume (Units), Forecast, 2008-2015
    • Table 68: Infusion Systems, China, Distribution Share by Revenue ($mn), 2007-2008
    • Table 69: Inhalation Systems, China, Distribution Share by Revenue ($mn), 2007-2008
    • Table 70: Drug Delivery Devices, China, Company Share by Revenue ($ mn), 2006-2007
    • Table 71: Infusion Systems, China, Company Share by Revenue ($ mn), 2006-2007
    • Table 72: Inhalation Systems, China, Company Share by Revenue ($ mn), 2006-2007
    • Table 73: Drug Delivery Devices, United Kingdom, Overall Revenue ($ mn), 2000-2015
    • Table 74: Drug Delivery Devices, United Kingdom, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 75: Drug Delivery Devices, United Kingdom, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 76: Drug Delivery Devices, United Kingdom, Category Volume (Units), 2000-2015
    • Table 77: Drug Delivery Devices, United Kingdom, Category Volume (Units), Historic, 2000-2008
    • Table 78: Drug Delivery Devices, United Kingdom, Category Volume (Units), Forecast, 2008-2015
    • Table 79: Infusion Systems, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
    • Table 80: Inhalation Systems, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
    • Table 81: Needle Free Injections, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
    • Table 82: Drug Delivery Devices, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 83: Infusion Systems, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 84: Inhalation Systems, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 85: Needle Free Injections, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 86: Drug Delivery Devices, Italy, Overall Revenue ($ mn), 2000-2015
+44 20 8816 8548

Ask a question about Global Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Enter the characters you see in the picture below
Captcha